Skip to main content

Life Sciences

What Pharmacovigilance Means And Why It Matters

Pharmacovigilance, or the practice of monitoring the effects of medicines after they have been released for commercial use, was expanded in 2002 by the World Health Organization (WHO) to include signal detection as a way of improving patient care and improving the overall health and safety of the general public. Today, pharmacovigilance activities should also contribute to the risk-benefit profile of the drug of interest.

Life Sciences - How Artificial Intelligence Can Enhance the Clinical Data Review and Cleaning Process
How Artificial Intelligence Can Enhance the Clinical Data Review and Cleaning Process

Learn how AI/ML can be used by pharmaceutical and medical device companies to improve the clinical data review and cleansing process.

Get the Guide

It is also interesting to note that the WHO sees pharmacovigilance as having a role in helping the general public better understand the safety monitoring of individual drugs. In essence, this implies that the safety profiles of drugs should not reside solely with marketing authorization holders and regulatory authorities, but should instead be shared with the broader community.

Check back for the next post in this series on drug safety: post-marketing surveillance. While you wait, enjoy this guide on drug safety.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Indy Ahluwalia

More from this Author

Categories
Follow Us
TwitterLinkedinFacebookYoutubeInstagram